{"id":3106,"date":"2015-11-20T07:30:00","date_gmt":"2015-11-20T07:30:00","guid":{"rendered":"https:\/\/www.xvivogroup.com\/us\/mfn_news\/steen-solution-godkant-i-kina\/"},"modified":"2015-11-20T07:30:00","modified_gmt":"2015-11-20T07:30:00","slug":"steen-solution-godkant-i-kina","status":"publish","type":"mfn_news","link":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/steen-solution-godkant-i-kina\/","title":{"rendered":"STEEN Solution\u2122 godk\u00e4nt i Kina"},"content":{"rendered":"
XVIVO Perfusion har erh\u00e5llit godk\u00e4nnande av China Food and Drug Administration (CFDA) f\u00f6r marknadsf\u00f6ring och klinisk anv\u00e4ndning av STEEN Solution\u2122 i Kina.<\/strong><\/div>\n<\/p>\n

CFDA har godk\u00e4nt STEEN Solution\u2122 f\u00f6r lungtransplantation, vilket m\u00f6jligg\u00f6r f\u00f6rs\u00e4ljning till klinisk anv\u00e4ndning av STEEN Solution\u2122 f\u00f6r lungtransplantationer i Kina. Kina st\u00e5r idag f\u00f6r mindre \u00e4n fem procent av alla lungtransplantationer i v\u00e4rlden, trots dess stora andel av befolkningen i v\u00e4rlden, men marknaden har visat snabb tillv\u00e4xt de senaste \u00e5ren och det finns ett stort behov av fler donerade lungor till lungtransplantation. <\/span><\/p>\n<\/p>\n

\u201dGodk\u00e4nnandet av STEEN Solution\u2122 i Kina \u00e4r viktigt f\u00f6r framtida tillv\u00e4xt eftersom det d\u00e4r finns ett stort behov av lungtransplantationer och ett intresse att utnyttja EVLP med STEEN Solution\u2122 f\u00f6r att \u00f6ka tillg\u00e4ngligheten p\u00e5 anv\u00e4ndbara donerade lungor. Att vara p\u00e5 plats tidigt i tillv\u00e4xtfasen och etablera produkterna \u00f6kar chanserna att bli ledande n\u00e4r marknaden v\u00e4l mognat\u201d s\u00e4ger VD Magnus Nilsson, XVIVO Perfusion.<\/span><\/p>\n<\/p>\n

G\u00f6teborg 20 november 2015<\/span><\/p>\n<\/p>\n

XVIVO Perfusion AB (publ)<\/span><\/p>\n

\n

F\u00f6r ytterligare information, v\u00e4nligen kontakta: <\/span><\/p>\n

Christoffer Rosenblad, CFO, tel: 031-788 21 59, e-post: christoffer.rosenblad@xvivoperfusion.com<\/a>
F\u00f6r ytterligare information om XVIVO Perfusions verksamhet h\u00e4nvisas till bolagets hemsida, www.xvivoperfusion.com<\/a><\/span><\/p>\n

Informationen l\u00e4mnades f\u00f6r publicering den 20 november 2015 kl. 08:30.<\/span><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

XVIVO Perfusion har erh\u00e5llit godk\u00e4nnande av China Food and Drug Administration (CFDA) f\u00f6r marknadsf\u00f6ring och klinisk anv\u00e4ndning av STEEN Solution\u2122…<\/p>\n","protected":false},"template":"","class_list":["post-3106","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn","mfn-news-tag-mfn-type-ir","mfn-news-tag-mfn-lang-sv","mfn-news-tag-mfn-regulatory","mfn-news-tag-mfn-regulatory-listing","mfn-news-tag-mfn-ci","mfn-news-tag-mfn-ci-other"],"acf":[],"yoast_head":"\nSTEEN Solution\u2122 godk\u00e4nt i Kina - XVIVO<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.xvivogroup.com\/us\/pressreleases\/steen-solution-godkant-i-kina\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"STEEN Solution\u2122 godk\u00e4nt i Kina - XVIVO\" \/>\n<meta property=\"og:description\" content=\"XVIVO Perfusion har erh\u00e5llit godk\u00e4nnande av China Food and Drug Administration (CFDA) f\u00f6r marknadsf\u00f6ring och klinisk anv\u00e4ndning av STEEN Solution\u2122...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.xvivogroup.com\/us\/pressreleases\/steen-solution-godkant-i-kina\/\" \/>\n<meta property=\"og:site_name\" content=\"United States\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/steen-solution-godkant-i-kina\\\/\",\"url\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/steen-solution-godkant-i-kina\\\/\",\"name\":\"STEEN Solution\u2122 godk\u00e4nt i Kina - XVIVO\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/#website\"},\"datePublished\":\"2015-11-20T07:30:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/steen-solution-godkant-i-kina\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/steen-solution-godkant-i-kina\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/steen-solution-godkant-i-kina\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"STEEN Solution\u2122 godk\u00e4nt i Kina\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/#website\",\"url\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/\",\"name\":\"United States\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"STEEN Solution\u2122 godk\u00e4nt i Kina - XVIVO","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/steen-solution-godkant-i-kina\/","og_locale":"en_US","og_type":"article","og_title":"STEEN Solution\u2122 godk\u00e4nt i Kina - XVIVO","og_description":"XVIVO Perfusion har erh\u00e5llit godk\u00e4nnande av China Food and Drug Administration (CFDA) f\u00f6r marknadsf\u00f6ring och klinisk anv\u00e4ndning av STEEN Solution\u2122...","og_url":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/steen-solution-godkant-i-kina\/","og_site_name":"United States","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/steen-solution-godkant-i-kina\/","url":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/steen-solution-godkant-i-kina\/","name":"STEEN Solution\u2122 godk\u00e4nt i Kina - XVIVO","isPartOf":{"@id":"https:\/\/www.xvivogroup.com\/us\/#website"},"datePublished":"2015-11-20T07:30:00+00:00","breadcrumb":{"@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/steen-solution-godkant-i-kina\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.xvivogroup.com\/us\/pressreleases\/steen-solution-godkant-i-kina\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/steen-solution-godkant-i-kina\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.xvivogroup.com\/us\/"},{"@type":"ListItem","position":2,"name":"STEEN Solution\u2122 godk\u00e4nt i Kina"}]},{"@type":"WebSite","@id":"https:\/\/www.xvivogroup.com\/us\/#website","url":"https:\/\/www.xvivogroup.com\/us\/","name":"United States","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.xvivogroup.com\/us\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/mfn_news\/3106","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/media?parent=3106"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}